G. Sesti Et Al. , "A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice," DIABETES OBESITY & METABOLISM , vol.22, no.5, pp.873-878, 2020
Sesti, G. Et Al. 2020. A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice. DIABETES OBESITY & METABOLISM , vol.22, no.5 , 873-878.
Sesti, G., Bardtrum, L., DAĞDELEN, S., Halladin, N., Haluzik, M., Orsy, P., ... Rodriguez, M.(2020). A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice. DIABETES OBESITY & METABOLISM , vol.22, no.5, 873-878.
Sesti, Giorgio Et Al. "A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice," DIABETES OBESITY & METABOLISM , vol.22, no.5, 873-878, 2020
Sesti, Giorgio Et Al. "A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice." DIABETES OBESITY & METABOLISM , vol.22, no.5, pp.873-878, 2020
Sesti, G. Et Al. (2020) . "A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice." DIABETES OBESITY & METABOLISM , vol.22, no.5, pp.873-878.
@article{article, author={Giorgio Sesti Et Al. }, title={A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice}, journal={DIABETES OBESITY & METABOLISM}, year=2020, pages={873-878} }